BIOREGENX, INC. Quarterly Liabilities and Equity in USD from Q4 2021 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Bioregenx, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2021 to Q1 2024.
Bioregenx, Inc. Liabilities and Equity for the quarter ending March 31, 2024 was $20.5M, a 26206% increase year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$20.5M	+$20.4M	+26206%	Mar 31, 2024	10-Q/A	2024-05-29
Q4 2023	$1.69M	+$1.63M	+2760%	Dec 31, 2023	10-Q/A	2024-05-29
Q3 2023	$34K			Sep 30, 2023	10-Q	2023-11-20
Q2 2023	$85.5K			Jun 30, 2023	10-Q	2023-08-15
Q1 2023	$78K			Mar 31, 2023	10-Q	2023-05-22
Q4 2022	$59.1K	-$68.6K	-53.7%	Dec 31, 2022	10-K	2024-04-12
Q4 2021	$128K			Dec 31, 2021	10-K	2023-04-04

* An asterisk sign (*) next to the value indicates that the value is likely invalid.